Literature DB >> 20726797

ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers.

Xuefeng Fang1, Wei Yu, Lisha Li, Jiaofang Shao, Na Zhao, Qiyun Chen, Zhiyun Ye, Sheng-Cai Lin, Shu Zheng, Biaoyang Lin.   

Abstract

SOX2 is an HMG box containing transcription factor that has been implicated in various types of cancer, but its role in colorectal cancers (CRC) has not been studied. Here we show that SOX2 is overexpressed in CRC tissues compared with normal adjacent tissues using immunohistochemical staining and RT-PCR. We also observed an increased SOX2 expression in nucleus of colorectal cancer tissues (46%, 14/30 cases vs. 7%, 2/30 adjacent tissues). Furthermore, knockdown of SOX2 in SW620 colorectal cancer cells decreased their growth rates in vitro cell line, and in vivo in xenograft models. ChIP-Seq analysis of SOX2 revealed a consensus sequence of wwTGywTT. An integrated expression profiling and ChIP-seq analysis show that SOX2 is involved in the BMP signaling pathway, steroid metabolic process, histone modifications, and many receptor-mediated signaling pathways such as IGF1R and ITPR2 (Inositol 1,4,5-triphosphate receptor, type 2).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726797     DOI: 10.1089/omi.2010.0053

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  35 in total

1.  Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.

Authors:  Xue-feng Fang; Wei-yi Zhang; Na Zhao; Wei Yu; Dong Ding; Xu Hong; Li-sha Li; Hua-rong Zhang; Shu Zheng; Biao-yang Lin
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

2.  Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway.

Authors:  Yang Li; Kangdong Chen; Lei Li; Rui Li; Juxin Zhang; Wu Ren
Journal:  Tumour Biol       Date:  2015-07-11

3.  DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.

Authors:  Lucas A Salas; Mariona Bustamante; Juan R Gonzalez; Esther Gracia-Lavedan; Victor Moreno; Manolis Kogevinas; Cristina M Villanueva
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells.

Authors:  Zhong Shi; Rui Bai; Zhi-xuan Fu; Yong-liang Zhu; Rong-fu Wang; Shu Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

Review 5.  The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.

Authors:  Kuancan Liu; Baoshun Lin; Meng Zhao; Xiangyue Yang; Min Chen; Anding Gao; Fei Liu; Jianwen Que; Xiaopeng Lan
Journal:  Cell Signal       Date:  2013-02-15       Impact factor: 4.315

Review 6.  Sox2: regulation of expression and contribution to brain tumors.

Authors:  Sheila Mansouri; Romina Nejad; Merve Karabork; Can Ekinci; Ihsan Solaroglu; Kenneth D Aldape; Gelareh Zadeh
Journal:  CNS Oncol       Date:  2016-05-27

7.  Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells.

Authors:  Chen Chen; Yachun Lu; Jie Liu; Lisha Li; Na Zhao; Biaoyang Lin
Journal:  Int J Clin Exp Med       Date:  2014-11-15

8.  LGR5 positivity defines stem-like cells in colorectal cancer.

Authors:  Daniela Hirsch; Nick Barker; Nicole McNeil; Yue Hu; Jordi Camps; Katherine McKinnon; Hans Clevers; Thomas Ried; Timo Gaiser
Journal:  Carcinogenesis       Date:  2013-11-26       Impact factor: 4.944

9.  Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.

Authors:  Xue-Feng Fang; Zhi-Bo Hou; Xin-Zheng Dai; Cong Chen; Jing Ge; Hong Shen; Xiao-Feng Li; Li-Ke Yu; Ying Yuan
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention.

Authors:  Xiaoyan Lou; Xu Han; Chengmeng Jin; Wei Tian; Wei Yu; Dong Ding; Lihua Cheng; Bingding Huang; Huawei Jiang; Biaoyang Lin
Journal:  OMICS       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.